Clinical and Translational Oncology

, Volume 11, Issue 3, pp 154–159 | Cite as

New approaches to female fertility preservation

  • Javier DomingoEmail author
  • Yanira Ayllón
  • Santiago Domingo
  • Ana Cobo
  • Juana Crespo
  • Antonio Pellicer


Survival rates have been improved in young cancer patients due to advances in oncologic treatments. It is necessary to focus on the consequences of cancer treatments and try to elude or at least prevent them. Menopause and infertility are two of the main causes for concern to those patients who survive cancer. When a solution is offered to these patients, their quality of life and self-esteem can be dramatically increased after therapy. Results observed in vitrified oocytes are similar to those achieved with fresh oocytes, giving this method great potential. Recommendations on fertility preservation should be focused on the oocyte vitrification method, which should be considered as the first option. Limitations of this approach are the need for ovarian stimulation, which means a 2–3 week period prior to chemotherapy and the possibility of high oestradiol levels when tumours are hormone dependent.


Fertility preservation Oocyte vitrification Follicular stimulation Ovarian tissue cryopreservation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lee S, Schover L, Partridge A et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931PubMedCrossRefGoogle Scholar
  2. 2.
    Meseguer M, Molina N, García-Velasco JA et al (2006) Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertil Steril 85:640–645PubMedCrossRefGoogle Scholar
  3. 3.
    Kuwayama M, Vajta G, Kato O, Leibo SP (2005) Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 11:300–308PubMedCrossRefGoogle Scholar
  4. 4.
    McVie JG (1999) Cancer treatment: the last 25 years. Cancer Treat Rev 25:323–331PubMedCrossRefGoogle Scholar
  5. 5.
    Thomson AB, Critchley HO, Wallace WHB (2002) Fertility and progeny. Eur J Cancer 38:1634–1644PubMedCrossRefGoogle Scholar
  6. 6.
    Linet M, Ries L, Smith MA et al (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051–1058PubMedCrossRefGoogle Scholar
  7. 7.
    Blumenfeld Z, Eckman A (2005) Tratamientos oncológicos y supervivencia folicular. In: Schneider J, García-Velasco JA (eds) Cáncer y reproducción. Cuadernos de Medicina Reproductiva. Adalia farma, Madrid, pp 33–43Google Scholar
  8. 8.
    Larsen EC, Müller J, Schmiegelow K et al (2003) Reduced ovarian function in a long-term survivors of radiation and chemotherapy-treated childhood cancer. J Clin Endocrinol Met 88:5307–5314CrossRefGoogle Scholar
  9. 9.
    Poniatowski BC, Grimm P, Cohen G (2001) Chemotherapy-induced menopause: a literature review. Cancer Invest 19:641–648PubMedCrossRefGoogle Scholar
  10. 10.
    Sonmezer M, Oktay K (2006) Fertility preservation in young women undergoing breast cancer therapy. Oncologist 11:422–434PubMedCrossRefGoogle Scholar
  11. 11.
    (2006) Surveillance, Epidemiology and End Results Program, 1975–2003, Division of Cancer Control and Population Sciences, National Cancer Institute, USAGoogle Scholar
  12. 12.
    Jemal A, Siegel R, Ward E et al (2006) Cancer statistics 2006. CA Cancer J Clin 56:106–130PubMedCrossRefGoogle Scholar
  13. 13.
    Fernández M, Cobo A, Remohí J (2005) Toxicidad gonadal de la quimio/radioterapia. In: Schneider J, García-Velasco JA (eds) Cáncer y reproducción. Cuadernos de Medicina Reproductiva. Adalia farma, Madrid, pp 25–31Google Scholar
  14. 14.
    Meirow D, Nugent D (2001) The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 7:535–543PubMedCrossRefGoogle Scholar
  15. 15.
    Chapman R, Sutcliffe SB, Malpas JS (1979) Cytotoxic induced ovarian failure in Hodgkin’s disease. JAMA 242:1877–1881PubMedCrossRefGoogle Scholar
  16. 16.
    Marcello MF, Nuciforo G, Romeo R et al (1990) Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer 66:2099–2104PubMedCrossRefGoogle Scholar
  17. 17.
    Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718–1729PubMedGoogle Scholar
  18. 18.
    Meirow D, Epstein M, Lewis H et al (2001) Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod 16:632–637PubMedCrossRefGoogle Scholar
  19. 19.
    Royal College of Obstetricians and Gynaecologists (2004) Pregnancy and breast cancer. Guideline no. 12Google Scholar
  20. 20.
    Hensley ML, Reichman BS (1998) Fertility and pregnancy after adjuvant therapy chemotherapy for breast cancer. Crit Rev Oncol Hematol 28:121–128PubMedCrossRefGoogle Scholar
  21. 21.
    Warne GL, Fairley KF, Hobbs JB, Martin FI (1973) Cyclophosphamide-induced ovarian failure. N Engl J Med 289:1159–1162PubMedGoogle Scholar
  22. 22.
    Familiari G, Caggiati A, Nottola SA et al (1993) Ultrastructure of human primordial follicles after combination chemotherapy for Hodgkin’s disease. Hum Reprod 8:2080–2087PubMedGoogle Scholar
  23. 23.
    Meirow D, Dor J, Kaufman B et al (2007) Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 22:1626–1633PubMedCrossRefGoogle Scholar
  24. 24.
    Morita Y, Perez GI, Paris F et al (2000) Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6:1109–1114PubMedCrossRefGoogle Scholar
  25. 25.
    Wallace WH, Thomson AB, Kelsey TW (2003) The radiosensitivity of human oocyte. Hum Reprod 18:117–121PubMedCrossRefGoogle Scholar
  26. 26.
    Wallace WH, Thomson AB, Saran F, Kelsey TW (2005) Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 62:738–744PubMedGoogle Scholar
  27. 27.
    Patrick K, Wallace WH, Critchley H (2003) Late reproductive effects of cancer treatment in female survivors of childhood malignancy. Curr Obstet Gynecol 13:369–372CrossRefGoogle Scholar
  28. 28.
    Saphner T, Tormey DC, Gray R (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14:2738–2746PubMedGoogle Scholar
  29. 29.
    Blakely LJ, Buzdarm AU, Lozada JA et al (2004) Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 100:465–469PubMedCrossRefGoogle Scholar
  30. 30.
    Gelber S, Coates AS, Goldhirsch A et al (2001) Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19:1671–1675PubMedGoogle Scholar
  31. 31.
    Velentgas P, Daling JR, Malone KE et al (1999) Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 85:2424–2432PubMedCrossRefGoogle Scholar
  32. 32.
    Del Mastro L, Catzeddu T, Venturini M (2006) Infertility and pregnancy after breast cancer: current knowledge and future perspectives. Cancer Treat Rev 32:417–422PubMedCrossRefGoogle Scholar
  33. 33.
    Cobo A, Kuwayama M, Pérez S et al (2007) Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril 89:1657–1664PubMedCrossRefGoogle Scholar
  34. 34.
    Venn A, Watson L, Bruinsma F et al (1999) Risk of cancer after use of fertility drugs with in vitro fertilization. Lancet 354:1586–1590PubMedCrossRefGoogle Scholar
  35. 35.
    Platet N, Cathiard AM, Gleizes M, Garcia M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51:55–67PubMedCrossRefGoogle Scholar
  36. 36.
    Sonmezer M, Akar ME, Oktay K (2005) Strong family history in women who were diagnosed with breast cancer after in vitro fertilization. Fertil Steril 84:233–234CrossRefGoogle Scholar
  37. 37.
    Oktay K, Buyuk E, Libertella N et al (2005) Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347–4353PubMedCrossRefGoogle Scholar
  38. 38.
    Oktay K, Hourvitz A, Sahin G et al (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885–3890PubMedCrossRefGoogle Scholar
  39. 39.
    GarcíaVelasco JA, Moreno L, Pacheco A et al (2005) Aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 84:82–87CrossRefGoogle Scholar
  40. 40.
    Goss PE, Ingle JN, Martino S et al (2003) A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for earlystage breast cancer. N Engl J Med 349:1793–1802PubMedCrossRefGoogle Scholar
  41. 41.
    Healey S, Tan SL, Biljan MM, Tulandi T (2002) Letrozole and gonadotropins: what is the ideal patient protocol? Fertil Steril 78[Suppl 1]:S55CrossRefGoogle Scholar
  42. 42.
    Sánchez M, Alamá P, Gadea B et al (2007) Fresh human orthotopic ovarian cortex transplantation: long-term results. Hum Reprod 22:786–791PubMedCrossRefGoogle Scholar
  43. 43.
    Donnez J, Dolmans MM, Demylle D et al (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364:1405–1410PubMedCrossRefGoogle Scholar
  44. 44.
    Meirow D, Levron J, Eldar-Geva T et al (2005) Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353:318–321PubMedCrossRefGoogle Scholar
  45. 45.
    Demeestere I, Simon P, Buxant F et al (2006) Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Human Reprod 21:2010–2014CrossRefGoogle Scholar
  46. 46.
    Silber SJ, Lenahan KM, Levine DJ et al (2005) Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N Engl J Med 353:58–63PubMedCrossRefGoogle Scholar
  47. 47.
    Silber SJ, Derosa M, Pineda J e al (2008) A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum Reprod 23:1531–1537PubMedCrossRefGoogle Scholar
  48. 48.
    Andersen CY, Rosendahl M, Byskov AG et al (2008) Successful autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 23:2266–2272PubMedCrossRefGoogle Scholar
  49. 49.
    The Ethics Committee of the American Society for Reproductive Medicine (2005) Fertility preservation and reproduction in cancer patients. Fertil Steril 83:1622–1628CrossRefGoogle Scholar
  50. 50.
    Fernández E, Balagueró L (2005) Riesgo de fallo ovárico precoz tras tratamientos oncológicos. In: Schneider J, García-Velasco JA (eds) Cáncer y reproducción. Cuadernos de Medicina Reproductiva. Adalia farma, Madrid, pp 45–56Google Scholar
  51. 51.
    Srkalovic G, Schally AV, Wittliff JL et al (1998) Presence and characteristics of receptors for [D-Trp6] luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer. Int J Oncol 12:489–498PubMedGoogle Scholar
  52. 52.
    Emons G, Grundker C, Gunthert AR et al (2003) GnRH antagonists in the treatment of gynecological and breast cancers. Endocr Relat Cancer 10:291–299PubMedCrossRefGoogle Scholar
  53. 53.
    Fabbri R, Porcu E, Marsella T et al (2000) Technical aspects of oocyte cryopreservation. Mol Cell Endocrinol 169:39–42PubMedCrossRefGoogle Scholar
  54. 54.
    Van Uem JF, Siebzehnrübl ER, Schuh B et al (1987) Birth after cryopreservation of unfertilized oocytes. Lancet 1:752–753PubMedGoogle Scholar
  55. 55.
    Gook DA, Osborn SM, Bourne H, Johnston WI (1994) Fertilization of human oocytes following cryopreservation; normal karyotypes and absence of stray chromosomes. Hum Reprod 9:684–691PubMedGoogle Scholar
  56. 56.
    Blumenfeld Z, Avivi I, Eckman A et al (2008) Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89:166–173PubMedCrossRefGoogle Scholar
  57. 57.
    Jurema MW, Nogueira D (2006) In vitro maturation of human oocytes for assisted reproduction. Fertil Steril 86:1277–1291PubMedCrossRefGoogle Scholar
  58. 58.
    Brounet F, Bou C, Guillén A (2007) Maduración in vitro de ovocitos. In: García-Velasco JA, Requena A (eds) El óvulo: implicación en reproducción humana. Cuadernos de Medicina Reproductiva. Adalia farma, Madrid, pp 65–71Google Scholar

Copyright information

© Feseo 2009

Authors and Affiliations

  • Javier Domingo
    • 1
    Email author
  • Yanira Ayllón
    • 1
  • Santiago Domingo
    • 1
  • Ana Cobo
    • 1
  • Juana Crespo
    • 1
  • Antonio Pellicer
    • 1
  1. 1.Instituto Valenciano de InfertilidadIVI ValenciaValenciaSpain

Personalised recommendations